Disposition of 332 shares by Corey Manley of Omnicell at 29.25 subject to Rule 16b-3
OMCL Stock | USD 30.51 0.09 0.30% |
About 52% of Omnicell's investor base is interested to short. The analysis of overall sentiment of trading Omnicell stock suggests that many investors are impartial at this time. Omnicell's investing sentiment shows overall attitude of investors towards Omnicell.
Filed transaction by Omnicell Officer: Evp&chief Legal/admin Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Omnicell Fundamental Analysis
We analyze Omnicell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omnicell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omnicell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Omnicell is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Omnicell Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Omnicell stock to make a market-neutral strategy. Peer analysis of Omnicell could also be used in its relative valuation, which is a method of valuing Omnicell by comparing valuation metrics with similar companies.
Peers
Omnicell Related Equities
OFIX | Orthofix Medical | 13.46 | ||||
NRC | National Research | 1.10 | ||||
NEOG | Neogen | 0.43 | ||||
PRVA | Privia Health | 0.10 | ||||
HQY | HealthEquity | 0.13 | ||||
MMSI | Merit Medical | 1.04 | ||||
TBRG | TruBridge | 1.70 |
Check out Omnicell Hype Analysis, Omnicell Correlation and Omnicell Performance. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Computers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.